Prevalence of Parkinson’s disease across North America

Connie Marras, James C. Beck, James H. Bower, +8

npj Parkinson s Disease

Assessing the Temporal Relationship Between Cognition and Gait: Slow Gait Predicts Cognitive Decline in the Mayo Clinic Study of Aging

Michelle M. Mielke, Rosebud O. Roberts, Rodolfo Savica, +11

The Journals of Gerontology Series A

Medical records documentation of constipation preceding Parkinson disease

Rodolfo Savica, J. M. Carlin, Brandon R. Grossardt, +5

Neurology

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72

Bradley F. Boeve, Neill R. Graff‐Radford, Mariely DeJesus‐Hernandez, +29

Brain

Motor Neuron DiseaseCorticobasal DegenerationGeneticsPathologyDisease Gene Identification +15

Incidence of Dementia With Lewy Bodies and Parkinson Disease Dementia

Rodolfo Savica, Brandon R. Grossardt, James H. Bower, +3

JAMA Neurology

Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study

Katrina Moore, Jennifer Nicholas, Murray Grossman, +167

The Lancet Neurology

Disease DurationNeurodegenerative DiseasesAlzheimer's DiseaseAgingGenetic Frontotemporal Dementia +13

Incidence of Parkinson disease in North America

Allison W. Willis, Eric Roberts, James C. Beck, +13

npj Parkinson s Disease

Time Trends in the Incidence of Parkinson Disease

Rodolfo Savica, Brandon R. Grossardt, James H. Bower, +2

JAMA Neurology

Plasma Ceramide and Glucosylceramide Metabolism Is Altered in Sporadic Parkinson's Disease and Associated with Cognitive Impairment: A Pilot Study

Michelle M. Mielke, Walter Maetzler, Norman J. Haughey, +9

PLoS ONE

Association of Plasma Total Tau Level With Cognitive Decline and Risk of Mild Cognitive Impairment or Dementia in the Mayo Clinic Study on Aging

Michelle M. Mielke, Clinton E. Hagen, Alexandra Wennberg, +8

JAMA Neurology